Tumor-Originated Exosomal hsa-miR-3937 as a Minimally Invasive Early Biomarker for Liquid Biopsy of Colorectal Cancer

Figure 5

BCL2L12 was a target gene of hsa-miR-3937. (a) TargetScan was used to predicted the binding site of hsa-miR-3937 on the target gene BCL2L12. (b) Luciferase reporter was performed to examine the binding ability between hsa-miR-3937 and BCL2L12. (c) Cell apoptosis was used to analyze the function of SW480 after interfering BCL2L12 expression (ns, ; , ; , ; , ; , ).

(a)

(b)

(c)